ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 66 filers reported holding ONCOCYTE CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,000 | – | 17,890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,056,680 | $15,895,000 | 2.92% |
| IHT Wealth Management, LLC | 200 | $386,000 | 0.19% |
| Family Management Corp | 22,570 | $117,000 | 0.08% |
| Artal Group S.A. | 150,000 | $780,000 | 0.01% |
| Destination Wealth Management | 29,656 | $154,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 145,000 | $754,000 | 0.01% |
| Advisor Group, Inc. | 102 | $1,000 | 0.00% |
| FIFTH THIRD BANCORP | 210 | $1,000 | 0.00% |
| HUNTINGTON NATIONAL BANK | 10 | $0 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,233 | $12,000 | 0.00% |